Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.

Ann M Chodara1, Aimée Wattiaux2, Christie M Bartels3

  • 1Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA.

Current Rheumatology Reports
|April 1, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pragmatic Trial of a Shared Decision-Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ-SAFE Study.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus-A Systematic Review and Meta-Analysis.

Arthritis care & research·2026
Same author

Integrating Patient-Reported Quality Measures in Systemic Lupus Erythematosus: Development of the American College of Rheumatology Implementation Guide.

Arthritis care & research·2026
Same author

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Arthritis care & research·2026
Same author

Addressing Economic Insecurities Can Improve Patient-Reported Outcomes in Lupus.

Arthritis care & research·2026
Same author

Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

ACR open rheumatology·2025

Rheumatoid arthritis (RA) patients face higher cardiovascular disease (CVD) risks. This review clarifies current CVD risk management strategies for RA, highlighting gaps and opportunities in rheumatology care.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Rheumatoid arthritis (RA) is associated with a well-established increase in cardiovascular disease (CVD) risk.
  • Effective management strategies for this elevated CVD risk within rheumatology clinics remain unclear.

Purpose of the Study:

  • To critically review recent literature (past 5 years) on CVD risk management in RA.
  • To identify current knowledge and existing gaps in managing CVD risk for RA patients.

Main Methods:

  • Literature review of guidelines, recommendations, and evidence from the last five years.
  • Examination of RA-specific management, individual risk assessment, and population-level targeting of traditional CVD risk factors.

Main Results:

Keywords:
Cardiovascular diseaseHyperlipidemiaHypertensionRheumatoid arthritisRisk assessmentSmoking cessation

Related Experiment Videos

  • Recent guidelines and evidence were analyzed, focusing on three management approaches.
  • Opportunities exist within rheumatology care to integrate CVD risk reduction strategies, drawing from primary care successes and updated professional society guidelines.

Conclusions:

  • Further research is needed for evidence-based strategies to manage and reduce CVD risk in RA, particularly given the high percentage of RA visits in specialty clinics.
  • Integrating comprehensive CVD risk management into routine rheumatology care is crucial for improving patient outcomes.